慢性鼻窦炎局部治疗:激素洗脱鼻窦植入物
本文综述激素洗脱鼻窦植入物(Propel 系列与 Sinuva)治疗慢性鼻窦炎(CRS)的临床研究。共纳入 Propel 系列 4 项前瞻性随机临床研究和 Sinuva 2 项前瞻性随机临床研究,结果显示这些植入物可改善鼻内镜术后转归并治疗术后鼻息肉复发而无需额外鼻窦手术。
要点
- Propel 系列与 Sinuva 两类激素洗脱植入物均有前瞻性随机临床研究支持。
- 植入物可改善鼻内镜鼻窦手术(ESS)术后结果并治疗术后鼻息肉复发。
- 植入物可能替代全身激素对 CRS 患者的获益作用。
核心结论
- 新型激素洗脱植入物似乎对 CRS 患者术后即刻以及鼻息肉患者有益。
- 这些植入物可能替代全身激素对 CRS 患者的获益作用。
研究设计与样本
- 文献综述,检索评估激素洗脱植入物的临床研究。
- 识别出两类激素洗脱植入物:Propel 系列产品与 Sinuva。
- Propel 系列产品纳入 4 项前瞻性随机临床研究。
- Sinuva 纳入 2 项前瞻性随机临床研究。
主要发现
- 临床研究结果显示,使用各类激素洗脱鼻窦植入物可改善 ESS 术后结果。
- 临床研究结果显示,使用各类激素洗脱鼻窦植入物可治疗鼻窦手术后鼻息肉复发,无需额外鼻窦手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic rhinosinusitis (CRS) causes severe symptoms that lead to poor quality of life. When optimal medical therapy does not improve CRS symptoms, then endoscopic sinus surgery (ESS) can be used in patients with persistent symptoms and radiographic evidence of CRS to improve patients' symptoms and quality of life. Despite appropriate and complete sinus surgery, there can be issues after sinus surgery such as synechiae formation and recurrence of polyps in certain CRS patients that can decrease long-term outcomes. Corticosteroids are used to decrease postoperative scarring and edema as well as prevent recurrence of nasal polyp formation after sinus surgery. However, the use of oral or systemic steroid can lead to serious short-term and long-term complications. Therefore, a safer alternative would be the topical delivery of steroid via steroid-eluting sinus implants. METHODS: A literature review was performed to identify clinical studies evaluating steroid-eluting implants. Two forms of steroid-eluting implants were identified, Propel family products and Sinuva. The research findings from clinical studies using various steroid-eluting sinus implants are reviewed and discussed. RESULTS: Four prospective randomized clinical studies were identified for the Propel family products. Two prospective randomized clinical studies were identified for Sinuva. The results from the clinical studies showed that the use of the various steroid-eluting sinus implants can improve postoperative results after ESS as well as treat the recurrence of nasal polyps after sinus surgery without the need for additional sinus surgery. CONCLUSION: The novel steroid-eluting implants appear to be beneficial for CRS patients immediately post-operatively as well as for nasal polyps patients. Interestingly, these implants could be used as a substitute for the beneficial effect of systemic steroid use for CRS patients.
引用
- Han JK, Kern RC. Topical therapies for management of chronic rhinosinusitis: steroid implants. Int Forum Allergy Rhinol. 2019. PMID: 31087636. doi:10.1002/alr.22344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。